Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

J. G. Cui, Y. Zhao, P. Sethi, Y. Y. Li, A. Mahta, F. Culicchia, W. J. Lukiw

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

High density micro-RNA (miRNA) arrays, fluorescent-reporter miRNA assay and Northern miRNA dot-blot analysis show that a brain-enriched miRNA-128 is significantly down-regulated in glioblastoma multiforme (GBM) and in GBM cell lines when compared to age-matched controls. The down-regulation of miRNA-128 was found to inversely correlate with WHO tumor grade. Three bioinformatics-verified miRNA-128 targets, angiopoietin-related growth factor protein 5 (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated. Addition of exogenous miRNA-128 to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines. Our data suggests that down-regulation of miRNA-128 may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (ANGPTL6), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.

Original languageEnglish
Pages (from-to)298-304
Number of pages7
JournalJournal of Neuro-Oncology
Volume98
Issue number3
DOIs
StatePublished - Jul 1 2010

Fingerprint

Glioblastoma
MicroRNAs
Down-Regulation
Cell Proliferation
Brain
Cell Line
Angiopoietins
Cell Cycle Checkpoints
Computational Biology
Tumor Suppressor Genes
Glioma
Intercellular Signaling Peptides and Proteins
Transcription Factors
Neoplasms

Keywords

  • ARP5 (ANGPTL6)
  • Bmi-1
  • Cell-cycle control
  • Differentiation
  • Differentiation regulated transcription factors (DRTFs)
  • E2F-3
  • Glioblastoma multiforme (GBM)
  • Micro-RNA array
  • miRNA-128
  • Neural stem cell (NSC)
  • NSC renewal

ASJC Scopus subject areas

  • Clinical Neurology
  • Cancer Research
  • Oncology
  • Neurology

Cite this

Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. / Cui, J. G.; Zhao, Y.; Sethi, P.; Li, Y. Y.; Mahta, A.; Culicchia, F.; Lukiw, W. J.

In: Journal of Neuro-Oncology, Vol. 98, No. 3, 01.07.2010, p. 298-304.

Research output: Contribution to journalArticle

Cui, J. G. ; Zhao, Y. ; Sethi, P. ; Li, Y. Y. ; Mahta, A. ; Culicchia, F. ; Lukiw, W. J. / Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation. In: Journal of Neuro-Oncology. 2010 ; Vol. 98, No. 3. pp. 298-304.
@article{f015697018dd41748ec7205f72b41da5,
title = "Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation",
abstract = "High density micro-RNA (miRNA) arrays, fluorescent-reporter miRNA assay and Northern miRNA dot-blot analysis show that a brain-enriched miRNA-128 is significantly down-regulated in glioblastoma multiforme (GBM) and in GBM cell lines when compared to age-matched controls. The down-regulation of miRNA-128 was found to inversely correlate with WHO tumor grade. Three bioinformatics-verified miRNA-128 targets, angiopoietin-related growth factor protein 5 (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated. Addition of exogenous miRNA-128 to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines. Our data suggests that down-regulation of miRNA-128 may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (ANGPTL6), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.",
keywords = "ARP5 (ANGPTL6), Bmi-1, Cell-cycle control, Differentiation, Differentiation regulated transcription factors (DRTFs), E2F-3, Glioblastoma multiforme (GBM), Micro-RNA array, miRNA-128, Neural stem cell (NSC), NSC renewal",
author = "Cui, {J. G.} and Y. Zhao and P. Sethi and Li, {Y. Y.} and A. Mahta and F. Culicchia and Lukiw, {W. J.}",
year = "2010",
month = "7",
day = "1",
doi = "10.1007/s11060-009-0077-0",
language = "English",
volume = "98",
pages = "298--304",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "3",

}

TY - JOUR

T1 - Micro-RNA-128 (miRNA-128) down-regulation in glioblastoma targets ARP5 (ANGPTL6), Bmi-1 and E2F-3a, key regulators of brain cell proliferation

AU - Cui, J. G.

AU - Zhao, Y.

AU - Sethi, P.

AU - Li, Y. Y.

AU - Mahta, A.

AU - Culicchia, F.

AU - Lukiw, W. J.

PY - 2010/7/1

Y1 - 2010/7/1

N2 - High density micro-RNA (miRNA) arrays, fluorescent-reporter miRNA assay and Northern miRNA dot-blot analysis show that a brain-enriched miRNA-128 is significantly down-regulated in glioblastoma multiforme (GBM) and in GBM cell lines when compared to age-matched controls. The down-regulation of miRNA-128 was found to inversely correlate with WHO tumor grade. Three bioinformatics-verified miRNA-128 targets, angiopoietin-related growth factor protein 5 (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated. Addition of exogenous miRNA-128 to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines. Our data suggests that down-regulation of miRNA-128 may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (ANGPTL6), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.

AB - High density micro-RNA (miRNA) arrays, fluorescent-reporter miRNA assay and Northern miRNA dot-blot analysis show that a brain-enriched miRNA-128 is significantly down-regulated in glioblastoma multiforme (GBM) and in GBM cell lines when compared to age-matched controls. The down-regulation of miRNA-128 was found to inversely correlate with WHO tumor grade. Three bioinformatics-verified miRNA-128 targets, angiopoietin-related growth factor protein 5 (ARP5; ANGPTL6), a transcription suppressor that promotes stem cell renewal and inhibits the expression of known tumor suppressor genes involved in senescence and differentiation, Bmi-1, and a transcription factor critical for the control of cell-cycle progression, E2F-3a, were found to be up-regulated. Addition of exogenous miRNA-128 to CRL-1690 and CRL-2610 GBM cell lines (a) restored 'homeostatic' ARP5 (ANGPTL6), Bmi-1 and E2F-3a expression, and (b) significantly decreased the proliferation of CRL-1690 and CRL-2610 cell lines. Our data suggests that down-regulation of miRNA-128 may contribute to glioma and GBM, in part, by coordinately up-regulating ARP5 (ANGPTL6), Bmi-1 and E2F-3a, resulting in the proliferation of undifferentiated GBM cells.

KW - ARP5 (ANGPTL6)

KW - Bmi-1

KW - Cell-cycle control

KW - Differentiation

KW - Differentiation regulated transcription factors (DRTFs)

KW - E2F-3

KW - Glioblastoma multiforme (GBM)

KW - Micro-RNA array

KW - miRNA-128

KW - Neural stem cell (NSC)

KW - NSC renewal

UR - http://www.scopus.com/inward/record.url?scp=77953610190&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77953610190&partnerID=8YFLogxK

U2 - 10.1007/s11060-009-0077-0

DO - 10.1007/s11060-009-0077-0

M3 - Article

C2 - 19941032

AN - SCOPUS:77953610190

VL - 98

SP - 298

EP - 304

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 3

ER -